The note is the current scenario (Base). Download PDF renders this page on the server, fonts and colours exact; Print uses the browser.
Model Note · M K PROTEINS LIMITED · 29 October 2026Page 1 of 2
Model Note
Prepared by the reader · not a MarketPing document
M K PROTEINS LIMITED
Discounted cash flow · base FY26

M K PROTEINS LIMITED

Value per share, this model₹(22)
CMP, 28 Oct 2026₹3.67
Difference(701.1)%
Growth the CMP implies—

This note states the assumptions and the arithmetic of one model of M K PROTEINS LIMITED, built on its filed FY26 standalone statements. The value is the outcome of the assumptions below and nothing else; it is not a fair value, a target or a recommendation.

Assumptions

InputThis modelFiled reference
Revenue growth, 5 years30% a yearFY26 43.0% · 5-yr CAGR —%
EBITDA margin3%FY26 3.0% · 5-yr average 4.8%
Depreciation · capex, % of revenue0.1% · 0.5%, fading to 1.2× depreciationFY26 0.1% · 0.5%
Working capital, % of added revenue · tax27.9% · 27.3%102 working-capital days · effective 27.3%
Discount rate11.00%1-yr beta 1.27
After FY315% flat · mid-year discounting—
Net debt · non-controlling interest · non-operating investments₹36 · ₹0 · ₹0 crFY26 net debt ₹36 cr
Shares37.54 crore37.54 crore today
Source: SEBI results XBRL as filed with BSE/NSE, exchange prices; the reader's assumptions.

Projected cash flow to the firm

₹ croreFY26FY27FY28FY29FY30FY31
Revenue3834986478411,0941,422
growth %43.030.030.030.030.030.0
EBITDA111519253343
Depreciation(0)(0)(1)(1)(1)(1)
NOPAT81014182330
less capex(2)(2)(3)(3)(2)(2)
less working-capital build—(32)(42)(54)(70)(92)
Free cash flow to firm—(24)(30)(38)(49)(62)
Present value(22)(26)(29)(34)(39)
Source: the model; base year as filed.
Every figure is the reader's model over filed numbers · No rating, target or fair value is expressedmarketping.in
Model Note · M K PROTEINS LIMITED · 29 October 2026Page 2 of 2

From enterprise to equity

PV of the 5 explicit years(150)
PV of the terminal value (—% of EV)(642)
Enterprise value(792)
less net debt(36)
less non-controlling interest0
add non-operating investments0
Equity value(828)
÷ 37.54 crore shares₹(22)
Source: the model.

Sensitivity, ₹ per share

WACC ↓ · terminal growth →4.0%4.5%5.0%5.5%6.0%
10.0%(23)(24)(27)(29)(32)
10.5%(21)(22)(24)(26)(29)
11.0%(19)(21)(22)(24)(26)
11.5%(18)(19)(20)(22)(23)
12.0%(17)(18)(19)(20)(21)
Source: the model; n/a where terminal growth reaches the discount rate.

Statement

This note is the reader's own model over publicly filed information: SEBI results XBRL filed with BSE and NSE and exchange price data, assembled by MarketPing software; every assumption above is the reader's. It contains no research recommendation, no price target and no opinion by MarketPing on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Historical per-share figures are on the current share count. Where a figure is unavailable the table shows a dash rather than an estimate. Nothing here constitutes investment advice, an offer or a solicitation.

Every figure is the reader's model over filed numbers · No rating, target or fair value is expressedmarketping.in